Fibroblast growth factor 21 in patients with cardiac cachexia: a possible role of chronic inflammation

ConclusionsFibroblast growth factor 21 (FGF ‐21) levels were elevated in patients with HFrEF and cardiac cachexia, which could be mediated by increased inflammation and muscle wasting rather than impaired cardiac function.

Source: ESC Heart Failure - August 19, 2019 Category: Cardiology Authors: Maria Refsgaard Holm, Heidi Christensen, Jon Rasmussen, Marie Louise Johansen, Morten Schou, Jens Faber, Caroline Kistorp Tags: Original Research Article Source Type: research